These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16482921)

  • 1. [Expression of cyclooxygenase (COX)-2 in astrocytic tumors and anti-tumor effects of selective COX-2 inhibitors].
    Murakami H; Sawa H; Kamada H
    No To Shinkei; 2006 Jan; 58(1):43-9. PubMed ID: 16482921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
    Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.
    Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A
    Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway].
    Huang DS; Xu X; Zheng SS; Cheng JF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):601-5. PubMed ID: 16274041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
    Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
    Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
    Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
    Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
    Duan W; Zhang L
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants.
    Fu YG; Sung JJ; Wu KC; Wu HP; Yu J; Chan M; Chan VY; Chan KK; Fan DM; Leung WK
    Cancer Lett; 2005 Jun; 224(2):243-52. PubMed ID: 15914275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Bergmann F; Breinig M; Höpfner M; Rieker RJ; Fischer L; Köhler C; Esposito I; Kleeff J; Herpel E; Ehemann V; Friess H; Schirmacher P; Kern MA
    Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
    Leung E; McArthur D; Morris A; Williams N
    Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner.
    Kim SR; Park JH; Lee ME; Park JS; Park SC; Han JA
    Mech Ageing Dev; 2008 Dec; 129(12):706-13. PubMed ID: 18848576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.